At the 2025 ASCRS meeting, Dr Ang said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
ASCRS | videos
Endoscopic cyclophotocoagulation (ECP) has major potential for patients with glaucoma
Dr Richard Lindstrom speaks about the future of dry eye and shares pearls for young eye surgeons
David Lubeck, MD, talks about the biggest surprises from ASCRS in the glaucoma space
Josefina Botta, MD, MSc, discusses her real-world experiences with the RayOne EMV toric lens
The technology, which creates a 360-degree, instantaneous capsulotomy, appeared at the Eyecelerator event
Dr Nir Shoham-Hazon presented two papers detailing outcomes from the iTrack microcatheter at ASCRS in Boston
Elizabeth Yeu, MD, discusses a corneal case report at ASCRS 2024
At ASCRS, Dr Rom Kandavel discusses iStent outcomes for patients who have undergone laser peripheral iridotomy, trabeculectomy and SLT
At this year's ASCRS meeting, J. Morgan Micheletti, MD, talks about his research and the Young Eye Surgeons (YES) programme
William F. Wiley, MD, shares key takeaways from his presentation on binocularity and stereoacuity
Dr Neda Nikpoor discusses Light Adjustable Lenses and the implications for clinicians at ASCRS 2024
At ASCRS 2024, Aurion Biotech's Global VP Eris Jordan previews upcoming clinical data from North America and Asia
Jascha Wendelstein, MD, discusses the outcomes of a study comparing K and TK measurements
At ASCRS 2024, Oliver Findl, MD, provides an update on the ESCRS IOL calculator and new tools to come this year
Ahead of the ASCRS 2024 meeting, TheiaNova CEO Carissa Fonseca, PhD, pitched a novel keratoconus treatment
At the 2024 ASCRS meeting, Anthony Wallace details the presentations and educational programmes from Bausch + Lomb
At the ASCRS meeting in Boston, Dan Tran, MD, details his presentation on incision quality and clinical outcomes of femtosecond laser
At ASCRS in Boston, Paul Harasymowycz, MD shared a decade's worth of data on MIGS procedures for primary open-angle glaucoma
Adam Muzychuk, MD, BSc, FRCSC, discusses his ASCRS 2024 presentation on toric lens use for patients with low astigmatism
Greg Kunst, CEO of Aurion Biotech, discusses AURN001, a novel cell therapy targeting corneal endothelial disease
At ASCRS2024, George O. Waring IV, MD, FACS, provides an overview of his presentation highlighting outcomes for LASIK performed using an updated laser ablation algorithm
Filomena Ribeiro, MD, PhD, FEBO, discusses her presentation on neuroadaptation following the ASCRS Refractive Day
Sean Hanlon, CEO of CoFi, details the patient and provider benefits of recent CareCredit integration
Rich Small, CEO of Neurotech Pharmaceuticals, provides an update on the months ahead for NT-501 encapsulated cell therapy
Advertisement
Advertisement
